Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
PLoS ONE
2014
9
5
e96565
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells
Journal for ImmunoTherapy of Cancer
2014
2
1
Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy
Blood
2014
124
4
628-637
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Clinical Cancer Research
2013
19
12
3153-3164
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Journal of Clinical Investigation
2016
126
11
4262-4272
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
Cancer Immunology Research
2014
3
2
206-216
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Journal of Clinical Investigation
2016
126
6
2123-2138
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
Cancer Immunology Research
2014
3
2
125-135
Disparate Individual Fates Compose Robust CD8+ T Cell Immunity
Science
2013
340
6132
630-635
TCR-Ligand koff Rate Correlates with the Protective Capacity of Antigen-Specific CD8+ T Cells for Adoptive Transfer
Science Translational Medicine
2013
5
192
192ra87-192ra87